Cargando…

3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.

An analogue of meta-iodobenzylguanidine (MIBG) in which an aromatic hydrogen was replaced with fluorine has been found to possess many properties similar to those of the parent compound. Moreover, 4-fluoro-3-iodobenzylguanidine (FIBG) was retained in vitro by human neuroblastoma cells to a much grea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaidyanathan, G., Zhao, X. G., Larsen, R. H., Zalutsky, M. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223928/ https://www.ncbi.nlm.nih.gov/pubmed/9231923

Ejemplares similares

Enhancing the Therapeutic Effect of 2-(211)At-astato-α-methyl-L-phenylalanine with Probenecid Loading
por: Hanaoka, Hirofumi, et al.
Publicado: (2021)

Synthesis of [(211)At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution
por: Shirakami, Yoshifumi, et al.
Publicado: (2021)

Manual on the proper use of meta-[(211)At] astato-benzylguanidine ([(211)At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)
por: Ukon, Naoyuki, et al.
Publicado: (2022)

Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-(211)At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing
por: Ohshima, Yasuhiro, et al.
Publicado: (2019)

(18)F-meta-fluorobenzylguanidine ((18)F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models
por: Turnock, Stephen, et al.
Publicado: (2020)

Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model
por: Ohshima, Yasuhiro, et al.
Publicado: (2018)

Gold Nanostars: A Novel Platform for Developing (211)At-Labeled Agents for Targeted Alpha-Particle Therapy
por: Liu, Yang, et al.
Publicado: (2021)

OR03-01 Effects Of Alpha-emitting Meta-(211)At-astato-benzylguanidine ((211)At-MABG) Compared To (131)I-meta-iodobenzylguanidine ((131)I-MIBG) on Tumor Growth Suppression in a Pheochromocytoma Mouse Model
por: Yoshinaga, Keiichiro, et al.
Publicado: (2020)

Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
por: Vaidyanathan, G., et al.
Publicado: (1996)

Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
por: Batra, Vandana, et al.
Publicado: (2022)

Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.
por: Hauck, M. L., et al.
Publicado: (1998)

Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
por: Cunningham, S. H., et al.
Publicado: (1998)

Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
por: Larsen, R. H., et al.
Publicado: (1998)

Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab
por: Chitneni, Satish K., et al.
Publicado: (2019)

d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution
por: Pruszynski, Marek, et al.
Publicado: (2018)

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
por: Makvandi, Mehran, et al.
Publicado: (2022)

New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
por: Mairs, R. J., et al.
Publicado: (1995)

Properties of $^{211}_{85}$At$_{126}$ as observed in the decay of $^{211}$Rn
por: Astner, G
Publicado: (1972)

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.
por: Larsen, R. H., et al.
Publicado: (1994)

Prolonged Retention of the Placenta
Publicado: (1898)

Poster 211: Prolonged Opioid Use Following Distal Radius Fracture Fixation: Who is at Risk?
por: Runge, William, et al.
Publicado: (2023)

Prolonged Retention of a Vaginal Pessary
Publicado: (1930)

Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
por: Aurlien, E, et al.
Publicado: (2000)

Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice
por: Ukon, Naoyuki, et al.
Publicado: (2020)

WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
por: Richter, Mark, et al.
Publicado: (2015)

The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
por: Mairs, R. J., et al.
Publicado: (1991)

FGFR1 is a potential therapeutic target in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2022)

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice
por: Sudo, Hitomi, et al.
Publicado: (2019)

Charge radii and electromagnetic moments of $^{195–211}$At
por: Cubiss, J G, et al.
Publicado: (2018)

Memorandum: future of R-211
por: Favart, D, et al.
Publicado: (1982)

Pelvic neuroblastoma presenting with acute urinary retention and acute kidney injury
por: Shields, Lisa B.E., et al.
Publicado: (2019)

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
por: Cazes, Alex, et al.
Publicado: (2014)

Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
por: Nicolai, S, et al.
Publicado: (2015)

Silicone Oil Opacification after Prolonged Intraocular Retention
por: Chandra, Parijat, et al.
Publicado: (2021)

Experience of disruption of capsule endoscopy after prolonged retention
por: Furumoto, Yohei, et al.
Publicado: (2021)

Prolonged Retention of Life by Infants Who Have Not Breathed
por: Newman, James T.
Publicado: (1868)

Some E2 rates in $^{211}_{85}$At$_{126}$
por: Astner, G, et al.
Publicado: (1972)

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2016)

Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential
por: Heinly, Briana E., et al.
Publicado: (2022)

Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
por: Babich, J. W., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_vimmg8hg825230rq12pqu7ji3r